Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial.
Kathleen M SchmaindaM A PrahZ ZhangBradley S SnyderS D RandTodd R JensenDaniel P BarboriakJerrold L BoxermanPublished in: AJNR. American journal of neuroradiology (2019)
This study shows that dT1 can predict early progression comparable with the standard method but offers the potential for substantial time and cost savings for clinical trials.
Keyphrases
- clinical trial
- radiation therapy
- high resolution
- phase ii
- phase iii
- palliative care
- study protocol
- magnetic resonance
- artificial intelligence
- cross sectional
- risk factors
- open label
- magnetic resonance imaging
- risk assessment
- human health
- randomized controlled trial
- machine learning
- contrast enhanced
- locally advanced
- deep learning
- fluorescence imaging